These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29530158)

  • 1. Quality use of antipsychotic medicines inresidential aged care facilities in New Zealand.
    Ndukwe HC; Nishtala PS; Wang T; Tordoff JM
    J Prim Health Care; 2016 Dec; 8(4):335-343. PubMed ID: 29530158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand.
    Tordoff JM; Ailabouni NJ; Browne DP; Al-Sallami HS; Gray AR
    Int J Clin Pharm; 2016 Aug; 38(4):941-9. PubMed ID: 27241343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dispensing of psychotropic medicines to older people before and after they enter residential aged care.
    Harrison SL; Sluggett JK; Lang C; Whitehead C; Crotty M; Corlis M; Wesselingh SL; Inacio MC
    Med J Aust; 2020 Apr; 212(7):309-313. PubMed ID: 32045014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antipsychotics among people treated with medications for dementia in residential aged care facilities.
    Shin HY; Gadzhanova S; Roughead EE; Ward MB; Pont LG
    Int Psychogeriatr; 2016 Jun; 28(6):977-82. PubMed ID: 26775538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability between nursing homes in prevalence of antipsychotic use in patients with dementia.
    Kleijer BC; van Marum RJ; Frijters DH; Jansen PA; Ribbe MW; Egberts AC; Heerdink ER
    Int Psychogeriatr; 2014 Mar; 26(3):363-71. PubMed ID: 24252349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic medicine prescribing and polypharmacy for people with dementia entering residential aged care: the influence of changing general practitioners.
    Welberry HJ; Jorm LR; Schaffer AL; Barbieri S; Hsu B; Harris MF; Hall J; Brodaty H
    Med J Aust; 2021 Aug; 215(3):130-136. PubMed ID: 34198357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing antipsychotic drugs in care homes.
    Prentice A; Wright D
    Nurs Times; 2014 Jun 4-10; 110(23):12-5. PubMed ID: 25016733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia.
    Jessop T; Harrison F; Cations M; Draper B; Chenoweth L; Hilmer S; Westbury J; Low LF; Heffernan M; Sachdev P; Close J; Blennerhassett J; Marinkovich M; Shell A; Brodaty H
    Int Psychogeriatr; 2017 Aug; 29(8):1391-1403. PubMed ID: 28266282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug use among elderly nursing home residents in the United States.
    Kamble P; Chen H; Sherer J; Aparasu RR
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):187-97. PubMed ID: 19028374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and psychological symptoms of dementia and their management in care homes within the East of England: a postal survey.
    Backhouse T; Killett A; Penhale B; Burns D; Gray R
    Aging Ment Health; 2014 Mar; 18(2):187-93. PubMed ID: 23886404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period.
    Szczepura A; Wild D; Khan AJ; Owen DW; Palmer T; Muhammad T; Clark MD; Bowman C
    BMJ Open; 2016 Sep; 6(9):e009882. PubMed ID: 27650756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses.
    Phillips LJ; Birtley NM; Petroski GF; Siem C; Rantz M
    J Psychiatr Ment Health Nurs; 2018 Oct; 25(8):463-474. PubMed ID: 29911331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More action needed: Psychotropic prescribing in Australian residential aged care.
    Westbury J; Gee P; Ling T; Kitsos A; Peterson G
    Aust N Z J Psychiatry; 2019 Feb; 53(2):136-147. PubMed ID: 29488403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada.
    Stock KJ; Amuah JE; Lapane KL; Hogan DB; Maxwell CJ
    Drugs Aging; 2017 Jan; 34(1):39-53. PubMed ID: 27830567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study.
    Foebel AD; Liperoti R; Onder G; Finne-Soveri H; Henrard JC; Lukas A; Denkinger MD; Gambassi G; Bernabei R;
    J Am Med Dir Assoc; 2014 Dec; 15(12):911-7. PubMed ID: 25262195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical and effective: approaches to residential care for people with dementia.
    O'Sullivan G
    Dementia (London); 2013 Jan; 12(1):111-21. PubMed ID: 24336666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of behavioural problems associated with dementia in rural aged care.
    Ervin K; Finlayson S; Cross M
    Collegian; 2012; 19(2):85-95. PubMed ID: 22774350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of second-generation antipsychotic agents among elderly nursing home residents.
    Kamble P; Sherer J; Chen H; Aparasu R
    Psychiatr Serv; 2010 Feb; 61(2):130-6. PubMed ID: 20123817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in benzodiazepine and antipsychotic use in people aged 65 years and over in New Zealand.
    Jackson G; Gerard C; Minko N; Parsotam N
    N Z Med J; 2014 Jun; 127(1396):67-78. PubMed ID: 24997465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial.
    Richter C; Berg A; Fleischer S; Köpke S; Balzer K; Fick EM; Sönnichsen A; Löscher S; Vollmar HC; Haastert B; Icks A; Dintsios CM; Mann E; Wolf U; Meyer G
    Implement Sci; 2015 Jun; 10():82. PubMed ID: 26037324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.